Description

Oxaliplatin Powder for Solution for Infusions 5 mg/ml. №1 Vial

Ingredients:

Each vial contains Oxaliplatin 100 mg as a lyophilized powder for reconstitution.

Dosage:

The recommended dosage of Oxaliplatin is 85 mg/m² administered as a 2-hour intravenous infusion every 2 weeks.

Indications:

Oxaliplatin is indicated for the treatment of advanced colorectal cancer.

Contraindications:

Do not use Oxaliplatin in patients with a history of allergic reactions attributed to platinum compounds.

Directions:

Oxaliplatin should be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.

Scientific Evidence:

Studies have shown that Oxaliplatin, in combination with other chemotherapeutic agents, significantly improves progression-free survival and overall survival in patients with advanced colorectal cancer.

Additional Information:

It is important to monitor patients receiving Oxaliplatin for signs of peripheral neuropathy, as this is a common side effect of the medication.

Pharmacological Effects: Oxaliplatin is a platinum-based chemotherapy drug that works by interfering with the DNA in cancer cells, ultimately leading to cell death. It is particularly effective in treating colorectal cancer by inhibiting cell replication and growth.

Clinical Trials: Clinical trials have demonstrated the efficacy of Oxaliplatin in combination with 5-fluorouracil and leucovorin as a first-line treatment for metastatic colorectal cancer. The results showed a significant improvement in response rates and survival outcomes compared to traditional chemotherapy regimens.